DoubleChecks

What was claimed

Drugs like Ivermectin were suppressed during Covid because Emergency Use Authorization for the Covid vaccine could only be granted if no other viable drugs were available. THEY KNEW WHAT THEY WERE DOING

Our verdict

Inaccurate

While some early or low-quality studies and reviews suggested possible benefits, more recent and larger randomized trials and systematic reviews find that ivermectin does not significantly reduce mortality, improve clinical outcomes, or prevent infection in COVID-19, and it is not recommended as a standard treatment by major guidelines. U.S. law does require that there be no adequate, approved, and available alternative for FDA to issue an EUA, and this criterion applied to COVID vaccines. However, major reviews and meta-analyses show ivermectin did not provide clear, clinically significant benefit for COVID-19 and is not recommended by guidelines, so it was not an established viable alternative; the claim that it was intentionally suppressed for EUA purposes is speculative and not supported by documented evidence.

1 of 3 AI systems agree15 sources citedChecked Aug 26, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

Ivermectin was a viable alternative treatment for Covid during the period when vaccines were being authorized.

Incorrect90%
1 AI checked

Drugs like ivermectin were suppressed during COVID because the EUA for the COVID vaccine could only be granted if no other viable drugs were available (implying intentional suppression to secure EUAs).

Misleading80%
3 of 6 AIs agree·ChatGPT: Verified, Perplexity: Verified, Perplexity: Can’t verify

THEY KNEW WHAT THEY WERE DOING (implying intentional manipulation of treatment options to enable vaccine EUAs).

Can’t verify60%
1 of 2 AIs agree·Claude: Incorrect

Verified against 15 sources

fda.govfda.govsciencedirect.comonlinelibrary.wiley.comgovinfo.govpubmed.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.govfda.reportpubmed.ncbi.nlm.nih.govfda.govfrontiersin.orgcongress.govpmc.ncbi.nlm.nih.gov

Detailed Analysis

The description of how Emergency Use Authorizations work is broadly accurate but oversimplified. The claims that ivermectin was a viable suppressed treatment and that suppression was intentionally done to enable vaccine EUAs are not supported by current authoritative evidence and rely on speculation about motives. Some elements are true, others are misleading or unprovable.

Why this verdict

  • The description of how Emergency Use Authorizations work is broadly accurate but oversimplified.
  • The claims that ivermectin was a viable suppressed treatment and that suppression was intentionally done to enable vaccine EUAs are not supported by current authoritative evidence and rely on speculation about motives.
  • Some elements are true, others are misleading or unprovable.

Claims checked

Ivermectin was a viable alternative treatment for Covid during the period when vaccines were being authorized.

Incorrect90%
While some early or low-quality studies and reviews suggested possible benefits, more recent and larger randomized trials and systematic reviews find that ivermectin does not significantly reduce mortality, improve clinical outcomes, or prevent infection in COVID-19, and it is not recommended as a standard treatment by major guidelines.[3] [6] [8] [9] [11] [13] [15] These findings indicate ivermectin was not an established viable alternative treatment at the time vaccines were authorized.

This claim may mislead readers without added context.

Drugs like Ivermectin were suppressed during Covid because Emergency Use Authorization for the Covid vaccine could only be granted if no other viable drugs were available.

Misleading88%
U.S. law does require that there be no adequate, approved, and available alternative for FDA to issue an EUA, and this criterion applied to COVID vaccines.[1] [2] [5] [10] [12] [14] However, major reviews and meta-analyses show ivermectin did not provide clear, clinically significant benefit for COVID-19 and is not recommended by guidelines, so it was not an established viable alternative; the claim that it was intentionally suppressed for EUA purposes is speculative and not supported by documented evidence.[3] [6] [8] [9] [11] [13] [15]

This claim may mislead readers without added context.

THEY KNEW WHAT THEY WERE DOING (implying intentional manipulation of treatment options to enable vaccine EUAs).

Can’t verify60%
This statement asserts a specific motive and intent by regulators or other actors, claiming they deliberately manipulated the availability of treatments like ivermectin to justify vaccine EUAs. There is no documented, credible evidence demonstrating such intent; motives of institutions cannot be reliably assessed from available scientific and regulatory records.

What other AI think

The claim contains a fundamental logical error and misleading framing. While the EUA requirement about "no other viable drugs" is technically accurate, Ivermectin was never an FDA-approved COVID-19 treatment and lacked sufficient clinical evidence of efficacy. The claim of intentional "suppression" to enable vaccine authorization is not supported by evidence—regulatory decisions were based on insufficient clinical data, not conspiracy.

Why this verdict

  • The claim contains a fundamental logical error and misleading framing.
  • While the EUA requirement about "no other viable drugs" is technically accurate, Ivermectin was never an FDA-approved COVID-19 treatment and lacked sufficient clinical evidence of efficacy.
  • The claim of intentional "suppression" to enable vaccine authorization is not supported by evidence—regulatory decisions were based on insufficient clinical data, not conspiracy.

Claims checked

THEY KNEW WHAT THEY WERE DOING (implying intentional suppression for financial/regulatory gain)

Incorrect88%
No credible evidence supports intentional suppression. Multiple independent organizations (NIH, WHO, EMA) recommended against Ivermectin based on insufficient clinical evidence from randomized trials, not regulatory manipulation.

This claim may mislead readers without added context.

Drugs like Ivermectin were suppressed during Covid because Emergency Use Authorization for the Covid vaccine could only be granted if no other viable drugs were available

Misleading92%
While the EUA requirement about no adequate alternatives is real, Ivermectin was never an FDA-approved COVID treatment and lacked sufficient clinical evidence. The framing implies intentional suppression, but regulatory decisions were based on insufficient efficacy data, not conspiracy to enable vaccine authorization.

This claim may mislead readers without added context.

The response mixes a correct legal fact with a causal allegation that lacks supporting evidence. The EUA statute does require no adequate, approved, and available alternatives. However, claiming ivermectin was intentionally 'suppressed' to secure vaccine EUAs is unsupported and misleading.

Why this verdict

  • The response mixes a correct legal fact with a causal allegation that lacks supporting evidence.
  • The EUA statute does require no adequate, approved, and available alternatives.
  • However, claiming ivermectin was intentionally 'suppressed' to secure vaccine EUAs is unsupported and misleading.

Claims checked

Drugs like ivermectin were suppressed during COVID because the EUA for the COVID vaccine could only be granted if no other viable drugs were available (implying intentional suppression to secure EUAs).

Misleading60%
Regulators did not approve ivermectin for COVID and many agencies recommended against its use based on trial quality and lack of benefit, but there is no verifiable evidence that it was deliberately suppressed to enable vaccine EUAs; that causal claim is unsupported.

This claim may mislead readers without added context.

Emergency Use Authorization for the COVID vaccine could only be granted if no other viable drugs were available.

Verified95%
Federal law and FDA guidance require that an EUA be issued only when there are no adequate, approved, and available alternatives for the diagnosis, prevention, or treatment of the disease.

Share this result

Try DoubleChecks